149 related articles for article (PubMed ID: 20009940)
1. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission.
Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940
[TBL] [Abstract][Full Text] [Related]
2. Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis.
Brandão DF; Ramalho FS; Martinelli AL; Zucoloto S; Ramalho LN
Pathol Res Pract; 2010 Dec; 206(12):800-4. PubMed ID: 20926203
[TBL] [Abstract][Full Text] [Related]
3. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
Guido M; Rugge M; Leandro G; Fiel IM; Thung SN
Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
[TBL] [Abstract][Full Text] [Related]
4. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
[TBL] [Abstract][Full Text] [Related]
5. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
6. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH
J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868
[TBL] [Abstract][Full Text] [Related]
7. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
8. Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis.
Ferreira AR; Roquete ML; Toppa NH; de Castro LP; Fagundes ED; Penna FJ
J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):65-70. PubMed ID: 18162836
[TBL] [Abstract][Full Text] [Related]
9. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis.
Mehendiratta V; Mitroo P; Bombonati A; Navarro VJ; Rossi S; Rubin R; Herrine SK
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):98-103. PubMed ID: 18955163
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological characteristics and pathogenesis of autoimmune hepatitis].
Zhao J; Wang S; Sun Y; Zhou G; Liu P; Meng E; Xin S; Zhang T; Wang F; Mao Y; Li L; Li Y; Zhang H; Zhang L; Chen J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):27-30. PubMed ID: 11986740
[TBL] [Abstract][Full Text] [Related]
11. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
[TBL] [Abstract][Full Text] [Related]
13. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.
D'Ambrosio R; Aghemo A; Rumi MG; Ronchi G; Donato MF; Paradis V; Colombo M; Bedossa P
Hepatology; 2012 Aug; 56(2):532-43. PubMed ID: 22271347
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
[TBL] [Abstract][Full Text] [Related]
15. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
[TBL] [Abstract][Full Text] [Related]
16. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study.
Akpolat N; Yahsi S; Godekmerdan A; Yalniz M; Demirbag K
Histopathology; 2005 Sep; 47(3):276-80. PubMed ID: 16115228
[TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
[TBL] [Abstract][Full Text] [Related]
18. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
[TBL] [Abstract][Full Text] [Related]
19. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
